Skip to main content
Top
Published in: BMC Primary Care 1/2022

Open Access 01-12-2022 | Care | Research

Applying the intervention Complexity Assessment Tool to brief interventions targeting long-term benzodiazepine receptor agonist use in primary care: Lessons learned

Authors: Aisling Barry, Simon Lewin, Cathal A. Cadogan

Published in: BMC Primary Care | Issue 1/2022

Login to get access

Abstract

Background

Benzodiazepine receptor agonists (BZRAs) are often prescribed for long-term use. However, guidelines recommend limiting prescriptions to short-term use (< 4 weeks) to reduce the risk of adverse effects and dependence. A recent systematic review reported that brief interventions targeting long-term BZRA use in primary care (e.g., short consultations, written letters to patients) were effective in helping patients to discontinue BZRA medication. However, the complexity of these interventions has not been examined in detail. This study aimed to apply the intervention Complexity Assessment Tool for Systematic Reviews (iCAT_SR) to brief interventions targeting long-term BZRA use. 

Methods

Two reviewers independently assessed the interventions using the six core iCAT_SR dimensions: organisational level/ category targeted, behaviour targeted, number of intervention components, degree of tailoring, skill level required by those delivering and receiving the intervention. The four optional iCAT_SR dimensions were applied where possible. A scoring system was using to calculate a complexity score for each intervention. Pearson’s correlations were used to assess the relationship between intervention complexity and effect size, as well as the relationship between intervention complexity and number of component behaviour change techniques (BCTs). Inter-rater reliability was calculated using Cohen’s Kappa coefficient.

Results

Four of the six core iCAT_SR dimensions were applied to the interventions with high inter-rater reliability (Cohen’s Kappa = 0.916). Application of the four optional dimensions was prevented by a lack of detail in study reports. Intervention complexity scores ranged from 8 to 11 (median: 11). There was no relationship detected between intervention complexity and either intervention effect size or number of component BCTs.

Conclusions

This study adds to the literature on worked examples of the practical application of the iCAT_SR. The findings highlight how more detailed reporting of interventions is needed in order to optimise the application of iCAT_SR and its potential to differentiate between interventions across the full range of complexity dimensions. Further work is needed to establish the validity of applying a scoring system to iCAT_SR assessments.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pottie K, Thompson W, Davies S, Grenier J, Sadowski CA, Welch V, et al. Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline. Can Fam Physician. 2018;64(5):339–51.PubMedPubMedCentral Pottie K, Thompson W, Davies S, Grenier J, Sadowski CA, Welch V, et al. Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline. Can Fam Physician. 2018;64(5):339–51.PubMedPubMedCentral
2.
go back to reference Benzodiazpine Committee. Benzodiazepines: Good Practice Guidelines for Clinicians. Dublin: Department of Health and Children; 2002. Benzodiazpine Committee. Benzodiazepines: Good Practice Guidelines for Clinicians. Dublin: Department of Health and Children; 2002.
5.
go back to reference Hayhoe B, Lee-Davey J. Tackling benzodiazepine misuse. BMJ. 2018;362:k3208. Hayhoe B, Lee-Davey J. Tackling benzodiazepine misuse. BMJ. 2018;362:k3208.
6.
go back to reference Roehrs T. Benzodiazepine receptor agonist safety. J Clin Sleep Med. 2005;1(04):e486–7.CrossRef Roehrs T. Benzodiazepine receptor agonist safety. J Clin Sleep Med. 2005;1(04):e486–7.CrossRef
7.
go back to reference Brandt J, Leong C. Benzodiazepines and Z-drugs: an updated review of major adverse outcomes reported on in epidemiologic research. Drugs R&D. 2017;17(4):493–507.CrossRef Brandt J, Leong C. Benzodiazepines and Z-drugs: an updated review of major adverse outcomes reported on in epidemiologic research. Drugs R&D. 2017;17(4):493–507.CrossRef
8.
go back to reference Neutel CI. The epidemiology of long-term benzodiazepine use. Int Rev Psychiatry. 2005;17(3):189–97.PubMedCrossRef Neutel CI. The epidemiology of long-term benzodiazepine use. Int Rev Psychiatry. 2005;17(3):189–97.PubMedCrossRef
9.
go back to reference Verthein U, Buth S, Holzbach R, Neumann-Runde E, Martens M-S. Benzodiazepines and z-drugs-analyses of ambulatory prescriptions from 2006 to 2015. Psychiatr Prax. 2019;46(7):399–405.PubMed Verthein U, Buth S, Holzbach R, Neumann-Runde E, Martens M-S. Benzodiazepines and z-drugs-analyses of ambulatory prescriptions from 2006 to 2015. Psychiatr Prax. 2019;46(7):399–405.PubMed
10.
go back to reference Cadogan CA, Ryan C, Cahir C, Bradley CP, Bennett K. Benzodiazepine and Z-drug prescribing in Ireland: analysis of national prescribing trends from 2005 to 2015. Br J Clin Pharmacol. 2018;84(6):1354–63.PubMedPubMedCentralCrossRef Cadogan CA, Ryan C, Cahir C, Bradley CP, Bennett K. Benzodiazepine and Z-drug prescribing in Ireland: analysis of national prescribing trends from 2005 to 2015. Br J Clin Pharmacol. 2018;84(6):1354–63.PubMedPubMedCentralCrossRef
11.
go back to reference Brandt J, Alessi-Severini S, Singer A, Leong C. Novel Measures Of Benzodiazepire & Z-drug utilisation trends in a Canadian provincial adult population (2001–2016). J Popul Ther Clin Pharmacol. 2019;26(1):e22–38.PubMedCrossRef Brandt J, Alessi-Severini S, Singer A, Leong C. Novel Measures Of Benzodiazepire & Z-drug utilisation trends in a Canadian provincial adult population (2001–2016). J Popul Ther Clin Pharmacol. 2019;26(1):e22–38.PubMedCrossRef
12.
go back to reference Bogunovic OJ, Greenfield SF. Practical geriatrics: use of benzodiazepines among elderly patients. Psychiatr Serv. 2004;55(3):233–5.PubMedCrossRef Bogunovic OJ, Greenfield SF. Practical geriatrics: use of benzodiazepines among elderly patients. Psychiatr Serv. 2004;55(3):233–5.PubMedCrossRef
13.
go back to reference Henman M, Vivero L, Gustafsson A, Mulvenna K. Benzodiazepine usage in the North Eastern Health Board region of the Republic of Ireland. 2004. Henman M, Vivero L, Gustafsson A, Mulvenna K. Benzodiazepine usage in the North Eastern Health Board region of the Republic of Ireland. 2004.
14.
go back to reference Sithamparanathan K, Sadera A, Leung L. Adverse effects of benzodiazepine use in elderly people: a meta-analysis. Asian J Gerontol Geriatr. 2012;7(2):107–11. Sithamparanathan K, Sadera A, Leung L. Adverse effects of benzodiazepine use in elderly people: a meta-analysis. Asian J Gerontol Geriatr. 2012;7(2):107–11.
15.
go back to reference Cadogan CA, Bradley CP, Bennett K. Impact of changes in controlled drugs legislation on benzodiazepine receptor agonist prescribing in Ireland: a repeated cross-sectional study. Eur J Clin Pharmacol. 2021;77(6):903–12.PubMedPubMedCentralCrossRef Cadogan CA, Bradley CP, Bennett K. Impact of changes in controlled drugs legislation on benzodiazepine receptor agonist prescribing in Ireland: a repeated cross-sectional study. Eur J Clin Pharmacol. 2021;77(6):903–12.PubMedPubMedCentralCrossRef
16.
go back to reference Fisher J, Sanyal C, Frail D, Sketris I. The intended and unintended consequences of benzodiazepine monitoring programmes: a review of the literature. J Clin Pharm Ther. 2012;37(1):7–21.PubMedCrossRef Fisher J, Sanyal C, Frail D, Sketris I. The intended and unintended consequences of benzodiazepine monitoring programmes: a review of the literature. J Clin Pharm Ther. 2012;37(1):7–21.PubMedCrossRef
17.
go back to reference Pollmann AS, Murphy AL, Bergman JC, Gardner DM. Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review. BMC Pharmacol Toxicol. 2015;16:19.PubMedPubMedCentralCrossRef Pollmann AS, Murphy AL, Bergman JC, Gardner DM. Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review. BMC Pharmacol Toxicol. 2015;16:19.PubMedPubMedCentralCrossRef
18.
go back to reference Lynch T, Ryan C, Hughes CM, Presseau J, van Allen ZM, Bradley CP, et al. Brief interventions targeting long-term benzodiazepine and Z-drug use in primary care: a systematic review and meta-analysis. Addiction. 2020;115(9):1618–39.PubMedPubMedCentralCrossRef Lynch T, Ryan C, Hughes CM, Presseau J, van Allen ZM, Bradley CP, et al. Brief interventions targeting long-term benzodiazepine and Z-drug use in primary care: a systematic review and meta-analysis. Addiction. 2020;115(9):1618–39.PubMedPubMedCentralCrossRef
19.
go back to reference Babor TF, McRee BG, Kassebaum PA, Grimaldi PL, Ahmed K, Bray J. Screening, Brief Intervention, and Referral to Treatment (SBIRT) toward a public health approach to the management of substance abuse. Substance abuse. 2007;28(3):7–30.PubMedCrossRef Babor TF, McRee BG, Kassebaum PA, Grimaldi PL, Ahmed K, Bray J. Screening, Brief Intervention, and Referral to Treatment (SBIRT) toward a public health approach to the management of substance abuse. Substance abuse. 2007;28(3):7–30.PubMedCrossRef
20.
go back to reference Agbadjé TT, Elidor H, Perin MS, Adekpedjou R, Légaré F. Towards a taxonomy of behavior change techniques for promoting shared decision making. Implement Sci. 2020;15(1):1–13.CrossRef Agbadjé TT, Elidor H, Perin MS, Adekpedjou R, Légaré F. Towards a taxonomy of behavior change techniques for promoting shared decision making. Implement Sci. 2020;15(1):1–13.CrossRef
21.
go back to reference Petticrew M. When are complex interventions ‘complex’? When are simple interventions ‘simple’? Eur J Pub Health. 2011;21(4):397–8.CrossRef Petticrew M. When are complex interventions ‘complex’? When are simple interventions ‘simple’? Eur J Pub Health. 2011;21(4):397–8.CrossRef
22.
go back to reference Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. Bmj. 2008;337:a1655.PubMedPubMedCentralCrossRef Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. Bmj. 2008;337:a1655.PubMedPubMedCentralCrossRef
23.
go back to reference Bleijenberg N, Janneke M, Trappenburg JC, Ettema RG, Sino CG, Heim N, et al. Increasing value and reducing waste by optimizing the development of complex interventions: Enriching the development phase of the Medical Research Council (MRC) Framework. Int J Nurs Stud. 2018;79:86–93.PubMedCrossRef Bleijenberg N, Janneke M, Trappenburg JC, Ettema RG, Sino CG, Heim N, et al. Increasing value and reducing waste by optimizing the development of complex interventions: Enriching the development phase of the Medical Research Council (MRC) Framework. Int J Nurs Stud. 2018;79:86–93.PubMedCrossRef
24.
go back to reference O’Cathain A, Croot L, Duncan E, Rousseau N, Sworn K, Turner KM, et al. Guidance on how to develop complex interventions to improve health and healthcare. BMJ Open. 2019;9(8):e029954.PubMedPubMedCentralCrossRef O’Cathain A, Croot L, Duncan E, Rousseau N, Sworn K, Turner KM, et al. Guidance on how to develop complex interventions to improve health and healthcare. BMJ Open. 2019;9(8):e029954.PubMedPubMedCentralCrossRef
25.
go back to reference Clark AM, Briffa TG, Thirsk L, Neubeck L, Redfern J. What football teaches us about researching complex health interventions. Bmj. 2012;345:e8316.PubMedCrossRef Clark AM, Briffa TG, Thirsk L, Neubeck L, Redfern J. What football teaches us about researching complex health interventions. Bmj. 2012;345:e8316.PubMedCrossRef
26.
go back to reference Wells M, Williams B, Treweek S, Coyle J, Taylor J. Intervention description is not enough: evidence from an in-depth multiple case study on the untold role and impact of context in randomised controlled trials of seven complex interventions. Trials. 2012;13(1):1–17.CrossRef Wells M, Williams B, Treweek S, Coyle J, Taylor J. Intervention description is not enough: evidence from an in-depth multiple case study on the untold role and impact of context in randomised controlled trials of seven complex interventions. Trials. 2012;13(1):1–17.CrossRef
27.
go back to reference Lewin S, Hendry M, Chandler J, Oxman AD, Michie S, Shepperd S, et al. Assessing the complexity of interventions within systematic reviews: development, content and use of a new tool (iCAT_SR). BMC Med Res Methodol. 2017;17(1):76.PubMedPubMedCentralCrossRef Lewin S, Hendry M, Chandler J, Oxman AD, Michie S, Shepperd S, et al. Assessing the complexity of interventions within systematic reviews: development, content and use of a new tool (iCAT_SR). BMC Med Res Methodol. 2017;17(1):76.PubMedPubMedCentralCrossRef
29.
go back to reference Cadogan CA, Rankin A, Lewin S, Hughes CM. Application of the intervention Complexity Assessment Tool for Systematic Reviews within a Cochrane review: an illustrative case study. HRB Open Res. 2020;3:31.PubMedPubMedCentralCrossRef Cadogan CA, Rankin A, Lewin S, Hughes CM. Application of the intervention Complexity Assessment Tool for Systematic Reviews within a Cochrane review: an illustrative case study. HRB Open Res. 2020;3:31.PubMedPubMedCentralCrossRef
30.
go back to reference Blackburn NE, Wilson JJ, McMullan II, Caserotti P, Giné-Garriga M, Wirth K, et al. The effectiveness and complexity of interventions targeting sedentary behaviour across the lifespan: a systematic review and meta-analysis. Int J Behav Nutr Phys Act. 2020;17(1):53.PubMedPubMedCentralCrossRef Blackburn NE, Wilson JJ, McMullan II, Caserotti P, Giné-Garriga M, Wirth K, et al. The effectiveness and complexity of interventions targeting sedentary behaviour across the lifespan: a systematic review and meta-analysis. Int J Behav Nutr Phys Act. 2020;17(1):53.PubMedPubMedCentralCrossRef
31.
go back to reference Jones RA, Blackburn NE, Woods C, Byrne M, van Femke F, Tully MA. Interventions promoting active transport to school in children: A systematic review and meta-analysis. Prev Med. 2019;123:232–41.PubMedCrossRef Jones RA, Blackburn NE, Woods C, Byrne M, van Femke F, Tully MA. Interventions promoting active transport to school in children: A systematic review and meta-analysis. Prev Med. 2019;123:232–41.PubMedCrossRef
32.
go back to reference Liu S, Gnjidic D, Nguyen J, Penm J. Effectiveness of interventions on the appropriate use of opioids for noncancer pain among hospital inpatients: A systematic review. Br J Clin Pharmacol. 2020;86(2):210–43.PubMedPubMedCentralCrossRef Liu S, Gnjidic D, Nguyen J, Penm J. Effectiveness of interventions on the appropriate use of opioids for noncancer pain among hospital inpatients: A systematic review. Br J Clin Pharmacol. 2020;86(2):210–43.PubMedPubMedCentralCrossRef
33.
go back to reference Bashir K, King M, Ashworth M. Controlled evaluation of brief intervention by general practitioners to reduce chronic use of benzodiazepines. Br J Gen Pract. 1994;44(386):408–12.PubMedPubMedCentral Bashir K, King M, Ashworth M. Controlled evaluation of brief intervention by general practitioners to reduce chronic use of benzodiazepines. Br J Gen Pract. 1994;44(386):408–12.PubMedPubMedCentral
34.
go back to reference Cormack MA, Sweeney KG, Hughes-Jones H, Foot GA. Evaluation of an easy, cost-effective strategy for cutting benzodiazepine use in general practice. Br J Gen Pract. 1994;44(378):5–8.PubMedPubMedCentral Cormack MA, Sweeney KG, Hughes-Jones H, Foot GA. Evaluation of an easy, cost-effective strategy for cutting benzodiazepine use in general practice. Br J Gen Pract. 1994;44(378):5–8.PubMedPubMedCentral
35.
go back to reference Heather N, Bowie A, Ashton H, McAvoy B, Spencer I, Brodie J, et al. Randomised controlled trial of two brief interventions against long-term benzodiazepine use: outcome of intervention. Addiction Research & Theory. 2004;12(2):141–54.CrossRef Heather N, Bowie A, Ashton H, McAvoy B, Spencer I, Brodie J, et al. Randomised controlled trial of two brief interventions against long-term benzodiazepine use: outcome of intervention. Addiction Research & Theory. 2004;12(2):141–54.CrossRef
36.
go back to reference Kuntz JL, Kouch L, Christian D, Hu W, Peterson PL. Patient Education and Pharmacist Consultation Influence on Nonbenzodiazepine Sedative Medication Deprescribing Success for Older Adults. Perm J. 2019;23:18–161.PubMedCrossRef Kuntz JL, Kouch L, Christian D, Hu W, Peterson PL. Patient Education and Pharmacist Consultation Influence on Nonbenzodiazepine Sedative Medication Deprescribing Success for Older Adults. Perm J. 2019;23:18–161.PubMedCrossRef
37.
go back to reference Navy HJ, Weffald L, Delate T, Patel RJ, Dugan JP. Clinical pharmacist intervention to engage older adults in reducing use of alprazolam. Consult Pharm. 2018;33(12):711–22.PubMedCrossRef Navy HJ, Weffald L, Delate T, Patel RJ, Dugan JP. Clinical pharmacist intervention to engage older adults in reducing use of alprazolam. Consult Pharm. 2018;33(12):711–22.PubMedCrossRef
38.
go back to reference Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med. 2014;174(6):890–8.PubMedCrossRef Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med. 2014;174(6):890–8.PubMedCrossRef
39.
go back to reference Vicens C, Fiol F, Llobera J, Campoamor F, Mateu C, Alegret S, et al. Withdrawal from long-term benzodiazepine use: randomised trial in family practice. Br J Gen Pract. 2006;56(533):958–63.PubMedPubMedCentral Vicens C, Fiol F, Llobera J, Campoamor F, Mateu C, Alegret S, et al. Withdrawal from long-term benzodiazepine use: randomised trial in family practice. Br J Gen Pract. 2006;56(533):958–63.PubMedPubMedCentral
40.
go back to reference Vicens C, Bejarano F, Sempere E, Mateu C, Fiol F, Socias I, et al. Comparative efficacy of two interventions to discontinue long-term benzodiazepine use: cluster randomised controlled trial in primary care. Br J Psychiatry. 2014;204(6):471–9.PubMedCrossRef Vicens C, Bejarano F, Sempere E, Mateu C, Fiol F, Socias I, et al. Comparative efficacy of two interventions to discontinue long-term benzodiazepine use: cluster randomised controlled trial in primary care. Br J Psychiatry. 2014;204(6):471–9.PubMedCrossRef
41.
go back to reference Higgitt AC, Lader M, Fonagy P. Clinical management of benzodiazepine dependence. Br Med J (Clin Res Ed). 1985;291(6497):688.CrossRef Higgitt AC, Lader M, Fonagy P. Clinical management of benzodiazepine dependence. Br Med J (Clin Res Ed). 1985;291(6497):688.CrossRef
42.
go back to reference Schweizer E, Rickels K, Case WG, Greenblatt DJ. Long-term therapeutic use of benzodiazepines: II. Effects of gradual taper. Arch Gen Psychiatry. 1990;47(10):908–15.PubMedCrossRef Schweizer E, Rickels K, Case WG, Greenblatt DJ. Long-term therapeutic use of benzodiazepines: II. Effects of gradual taper. Arch Gen Psychiatry. 1990;47(10):908–15.PubMedCrossRef
43.
45.
go back to reference Ng BJ, Le Couteur DG, Hilmer SN. Deprescribing benzodiazepines in older patients: impact of interventions targeting physicians, pharmacists, and patients. Drugs Aging. 2018;35(6):493–521.PubMedCrossRef Ng BJ, Le Couteur DG, Hilmer SN. Deprescribing benzodiazepines in older patients: impact of interventions targeting physicians, pharmacists, and patients. Drugs Aging. 2018;35(6):493–521.PubMedCrossRef
46.
go back to reference Candy B, Vickerstaff V, Jones L, King M. Description of complex interventions: analysis of changes in reporting in randomised trials since 2002. Trials. 2018;19(1):1–9.CrossRef Candy B, Vickerstaff V, Jones L, King M. Description of complex interventions: analysis of changes in reporting in randomised trials since 2002. Trials. 2018;19(1):1–9.CrossRef
47.
go back to reference Glasziou P, Chalmers I, Altman DG, Bastian H, Boutron I, Brice A, et al. Taking healthcare interventions from trial to practice. BMJ. 2010;341:c3852.PubMedCrossRef Glasziou P, Chalmers I, Altman DG, Bastian H, Boutron I, Brice A, et al. Taking healthcare interventions from trial to practice. BMJ. 2010;341:c3852.PubMedCrossRef
48.
go back to reference Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687.PubMedCrossRef Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687.PubMedCrossRef
49.
go back to reference Alonso-Coello P, Schünemann HJ, Moberg J, Brignardello-Petersen R, Akl EA, Davoli M, et al. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices 1.: Introduction. BMJ. 2016;353:i2016.PubMedCrossRef Alonso-Coello P, Schünemann HJ, Moberg J, Brignardello-Petersen R, Akl EA, Davoli M, et al. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices 1.: Introduction. BMJ. 2016;353:i2016.PubMedCrossRef
50.
go back to reference Rosenbaum SE, Moberg J, Glenton C, Schünemann HJ, Lewin S, Akl E, et al. Developing Evidence to Decision Frameworks and an Interactive Evidence to Decision Tool for Making and Using Decisions and Recommendations in Health Care. Glob Chall. 2018;2(9):1700081.PubMedPubMedCentralCrossRef Rosenbaum SE, Moberg J, Glenton C, Schünemann HJ, Lewin S, Akl E, et al. Developing Evidence to Decision Frameworks and an Interactive Evidence to Decision Tool for Making and Using Decisions and Recommendations in Health Care. Glob Chall. 2018;2(9):1700081.PubMedPubMedCentralCrossRef
52.
go back to reference Field A. Discovering statistics using IBM SPSS statistics (4th ed.). 2013. SAGE Publications Ltd. Field A. Discovering statistics using IBM SPSS statistics (4th ed.). 2013. SAGE Publications Ltd.
53.
go back to reference Hoffmann TC, Oxman AD, Ioannidis JP, Moher D, Lasserson TJ, Tovey DI, et al. Enhancing the usability of systematic reviews by improving the consideration and description of interventions. BMJ. 2017;358:j2998.PubMedCrossRef Hoffmann TC, Oxman AD, Ioannidis JP, Moher D, Lasserson TJ, Tovey DI, et al. Enhancing the usability of systematic reviews by improving the consideration and description of interventions. BMJ. 2017;358:j2998.PubMedCrossRef
54.
go back to reference Montgomery P, Underhill K, Gardner F, Operario D, Mayo-Wilson E. The Oxford Implementation Index: a new tool for incorporating implementation data into systematic reviews and meta-analyses. J Clin Epidemiol. 2013;66(8):874–82.PubMedPubMedCentralCrossRef Montgomery P, Underhill K, Gardner F, Operario D, Mayo-Wilson E. The Oxford Implementation Index: a new tool for incorporating implementation data into systematic reviews and meta-analyses. J Clin Epidemiol. 2013;66(8):874–82.PubMedPubMedCentralCrossRef
Metadata
Title
Applying the intervention Complexity Assessment Tool to brief interventions targeting long-term benzodiazepine receptor agonist use in primary care: Lessons learned
Authors
Aisling Barry
Simon Lewin
Cathal A. Cadogan
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Primary Care / Issue 1/2022
Electronic ISSN: 2731-4553
DOI
https://doi.org/10.1186/s12875-022-01775-y

Other articles of this Issue 1/2022

BMC Primary Care 1/2022 Go to the issue